Table 2.
Clinical and laboratory characteristics of the ET patients included in the study.
| Patients characteristics | |
|---|---|
| Number of patients | 233 |
| Median follow-up (months) | 48.4 (range 0.3–313) |
| Median age at diagnosis (years) | 65.9 (range 14.5–92) |
| Age <60 years | 87 (37.3%) |
| Age >60 years | 146 (62.7%) |
| Female | 160 (68.7%) |
| Male | 73 (31.3%) |
| 1 CVR | 92 (39.5%) |
| >1 CVR | 82 (35.2%) |
| JAK2 V617F positive/tested | 168/233 (72.1% of the total number of pts) |
| CALR mutated/tested | 21/65 (9% of the total number of pts) |
| MPL mutated/tested | 4/44 (1.7% of the total number of pts) |
| Triple negative | 40 (17.2% of the total number of pts) |
| Thrombosis before or at diagnosis | 48 (20.6%) |
| Thrombosis after diagnosis | 14 (6%) |